PIK3CB expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.478600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.409600E-01
Normal-vs-Stage2
6.439000E-01
Normal-vs-Stage3
5.345200E-01
Normal-vs-Stage4
4.779600E-01
Stage1-vs-Stage2
8.801800E-01
Stage1-vs-Stage3
2.975400E-01
Stage1-vs-Stage4
4.543000E-01
Stage2-vs-Stage3
1.379250E-01
Stage2-vs-Stage4
5.558600E-01
Stage3-vs-Stage4
2.482800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.897000E-01
Normal-vs-AfricanAmerican
6.231200E-01
Normal-vs-Asian
8.205000E-01
Caucasian-vs-AfricanAmerican
5.215400E-01
Caucasian-vs-Asian
9.773600E-01
AfricanAmerican-vs-Asian
6.305400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.145600E-01
Normal-vs-Female
8.023400E-01
Male-vs-Female
6.165600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.983400E-01
Normal-vs-Age(41-60Yrs)
5.069000E-01
Normal-vs-Age(61-80Yrs)
9.086200E-01
Normal-vs-Age(81-100Yrs)
6.959000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.119800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.070200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.238800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.554300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.277000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.227800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.192600E-01
Normal-vs-Daily Drinker
7.379800E-01
Normal-vs-Weekly Drinker
9.113200E-01
Normal-vs-Occasional Drinker
5.356200E-01
Normal-vs-Social Drinker
8.065800E-01
Non Drinker-vs-Daily Drinker
7.192400E-01
Non Drinker-vs-Weekly Drinker
5.289800E-01
Non Drinker-vs-Occasional Drinker
3.467200E-01
Non Drinker-vs-Social Drinker
3.383000E-01
Daily Drinker-vs-Weekly Drinker
4.177800E-01
Daily Drinker-vs-Occasional Drinker
6.228800E-01
Daily Drinker-vs-Social Drinker
2.656200E-01
Weekly Drinker-vs-Occasional Drinker
1.858990E-01
Weekly Drinker-vs-Social Drinker
8.990800E-01
Occasional Drinker-vs-Social Drinker
9.850200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.080600E-01
Normal-vs-Grade 2
2.677900E-02
Normal-vs-Grade 3
1.629740E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.080800E-03
Grade 1-vs-Grade 3
5.558100E-04
Grade 1-vs-Grade 4
2.080600E-01
Grade 2-vs-Grade 3
1.286620E-01
Grade 2-vs-Grade 4
2.677900E-02
Grade 3-vs-Grade 4
1.629740E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.967600E-01
Normal-vs-NonDiabetic
7.842800E-01
Diabetic-vs-NonDiabetic
3.977600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.083400E-01
Normal-vs-NoPancreatitis
8.662400E-01
Pancreatitis-vs-NoPancreatitis
1.347220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.592600E-01
Normal-vs-N1
6.730800E-01
N0-vs-N1
3.627200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.368780E-01
Normal-vs-TP53-NonMutant
8.758800E-01
TP53-Mutant-vs-TP53-NonMutant
3.15019999996835E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
